Search

everythinglearnresearchcommunity

for

Search:↓

Vitamin D is important for skin health and can help treat psoriasis, atopic dermatitis, and vitiligo.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Men and women have different levels and production of brain steroids, which may affect their risk for certain brain disorders.

The workshop discussed the role of a protein called calreticulin in health and disease, its potential as a treatment target, and its possible use as a disease marker.

Essential oils from Hedychium spicatum have potential for developing natural drugs with pain-blocking, fever-reducing, anti-inflammatory, and antioxidant properties.

Our microbiome may affect the development of the hair loss condition Alopecia Areata, but more research is needed to understand this relationship.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Stem-cell therapy shows promise for skin conditions but needs more research.

Light therapy on the brain shows promise for treating brain diseases and improving brain function.

Scientists have improved 3D models of human skin for research and medical uses, but still face challenges in perfectly replicating real skin.

Human skin xenografting could improve our understanding of skin development, renewal, and healing.

Thyroid disease can cause skin, hair, and nail problems, and treating the thyroid condition often improves these symptoms.

Men with androgenetic alopecia, or hair loss, often have abnormal blood flow in their small blood vessels, which might be linked to inflammation and stress.

DHT inhibition may increase spinal bone growth in ankylosing spondylitis.

Interferon and ribavirin can cause serious skin reactions and other health issues.

Further research is needed to understand how the microbiome affects hair loss in Alopecia Areata.

Patterned hair loss is relatively common in women and not usually a sign of serious health issues.

ALA-PDT is effective and safe for chronic X-ray dermatitis, providing complete or partial remission.

The woman's rare combination of diseases suggests an unknown factor may predispose individuals to multiple endocrine diseases.

Botox is effective for urinary incontinence, chronic migraines, and male pattern hair loss, and a new test for Botox antibodies is more humane.

The document concludes that diagnosing and treating Human African Trypanosomiasis is challenging, but new treatments like fexinidazole are promising.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

Dermoscopy is becoming essential for diagnosing skin conditions and is expected to be a standard tool for dermatologists.

Hormone imbalances from endocrine diseases can cause various skin conditions that help diagnose and treat these diseases early.

The document concludes that stem cell therapies lack solid proof of effectiveness, except for blood system treatments, and criticizes the ethical issues and commercial exploitation in the field.

Topical latanoprost and bimatoprost ophthalmic solutions don't help eyelash growth in patients with alopecia areata.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

Minoxidil effectively lowers blood pressure without major side effects.

Prolactin affects hair growth and skin conditions, and could be a target for new skin disease treatments.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.